BioPharma Pharma & Biopharma Manufacturing
BioVaxys Announces Bioproduction of BVX-1021
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), today announced that it has entered into an agreem...
March 21, 2022 | News
Veristat Expands its Expertise and Scale across Biopharma and Medtech
Veristat, a scientific-minded global clinical research organization (CRO), announced today the expansion and strengthening of its service capabilities by a...
March 08, 2022 | News
WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at its Wuxi City Site
The PAI focused on the drug product manufacturing of an innovative drug for one of WuXi STA’s partners. During a 5-day remote inspection from Novembe...
March 04, 2022 | News
Vetter’s extraordinary performance sweeps the board at the 2022 CMO Leadership Awards
Vetter’s high-level performance further substantiates its dedicated performance in customer-critical services Results affirm the approach, vision,...
March 03, 2022 | News
Thermo Fisher Scientific Continues Collaboration to Support Biopharmaceutical Discovery and Development
Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the internationa...
March 01, 2022 | News
GenScript Sets Up State-Of-Art Manufacturing Facility in Singapore to Strengthen Manufacturing Capability
The state-of-the-art site marks a significant expansion of the company's advanced protein and gene platforms, and is designed to provide high quality...
February 10, 2022 | News
Nanoform signs GMP manufacturing program with TargTex following formulation success
This follows a successful PoC (Proof of Concept) study where the hydrogel formulation developed by Nanoform (CESS®2 technology-based nanoparticles...
February 07, 2022 | News
Germfree launches novel mobile cleanroom technology for advanced therapies
Germfree’s biomanufacturing platform addresses current industry needs, while de-risking and future-proofing for a rapidly evolving industry. "The ind...
February 03, 2022 | News
CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma
Dr. Michael Quirmbach, Chief Executive Officer & President of CordenPharma said, "We welcome the three sites and their employees as new members to...
February 02, 2022 | News
I-Mab to Accelerate Commercialization of Innovative Biologics Drugs
This strategic partnership will accelerate I-Mab's commercialization strategy with an execution plan and timeline to commercialize its innovative assets, i...
January 31, 2022 | News
HaemaLogiX and Lonza Collaborate to Manufacture KappaMab
Lonza to manufacture drug substance for clinical supply of HaemaLogiX's lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facil...
January 28, 2022 | News
Beijing Handian Pharamceutical Held an Expert Seminar About TCM Global Application In Beijing
he seminar first discussed the main reason causes the traditional Chinese medicine hardly used in other countries, which including the complex and rich eff...
January 27, 2022 | News
Partnership with RoosterBio to advance scalable and continuous exosomes manufacturing
Univercells Technologies, a leading provider of novel biomanufacturing technologies for flexible and scalable viral production, announces today a strategic...
January 21, 2022 | News
Vetter's new clinical manufacturing site now officially authorized
Important milestone reached for the new site Additional filling capacities for early-stage clinical development First customer audits already completed...
January 20, 2022 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
